Dolby Laboratories Analyst Ratings
Dolby Laboratories Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/28/2023 | 6.06% | Rosenblatt | → $93 | Reiterates | Buy → Buy |
| 06/01/2023 | 6.06% | Rosenblatt | → $93 | Reiterates | Buy → Buy |
| 04/26/2023 | 2.63% | Rosenblatt | → $90 | Reiterates | → Buy |
| 04/14/2023 | 32.28% | Tigress Financial | → $116 | Reiterates | → Buy |
| 02/03/2023 | 2.63% | Rosenblatt | $85 → $90 | Maintains | Buy |
| 11/18/2022 | — | Barrington Research | Downgrades | Outperform → Market Perform | |
| 11/07/2022 | -3.07% | Rosenblatt | $90 → $85 | Maintains | Buy |
| 10/14/2022 | 32.28% | Tigress Financial | $128 → $116 | Maintains | Buy |
| 05/24/2022 | 2.63% | Rosenblatt | → $90 | Initiates Coverage On | → Buy |
| 08/02/2021 | 31.14% | Barrington Research | → $115 | Upgrades | Market Perform → Outperform |
| 01/29/2021 | 1.49% | B. Riley Securities | $79 → $89 | Maintains | Neutral |
| 06/24/2020 | -17.89% | B. Riley Securities | $68 → $72 | Downgrades | Buy → Neutral |
| 05/05/2020 | -25.88% | JP Morgan | $66 → $65 | Maintains | Overweight |
| 05/05/2020 | -22.45% | B. Riley Securities | $71 → $68 | Maintains | Buy |
| 04/15/2020 | -19.03% | B. Riley Securities | $60 → $71 | Maintains | Buy |
| 03/24/2020 | -31.58% | B. Riley Securities | $57 → $60 | Upgrades | Neutral → Buy |
| 03/24/2020 | -31.58% | B. Riley Securities | → $60 | Upgrades | Neutral → Buy |
| 03/18/2020 | -35% | B. Riley Securities | $71 → $57 | Maintains | Neutral |
| 03/13/2020 | -24.73% | JP Morgan | → $66 | Upgrades | Neutral → Overweight |
| 01/10/2020 | -16.75% | B. Riley Securities | → $73 | Downgrades | Buy → Neutral |
| 08/02/2019 | -16.75% | B. Riley Securities | $67 → $73 | Maintains | Neutral |
| 10/25/2018 | -28.16% | B. Riley Securities | $69 → $63 | Maintains | Neutral |
| 10/22/2018 | -8.77% | RF Lafferty | $81 → $80 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 07/28/2023 | 6.06% | 羅森布拉特 | →$93 | 重申 | 購買→購買 |
| 06/01/2023 | 6.06% | 羅森布拉特 | →$93 | 重申 | 購買→購買 |
| 04/26/2023 | 2.63% | 羅森布拉特 | →$90 | 重申 | →購買 |
| 04/14/2023 | 32.28% | 虎妞金融 | →$116 | 重申 | →購買 |
| 02/03/2023 | 2.63% | 羅森布拉特 | $85→$90 | 維護 | 買 |
| 2022年11月18日 | - | 巴靈頓研究公司 | 評級下調 | 跑贏→市場表現 | |
| 11/07/2022 | -3.07% | 羅森布拉特 | $90→$85 | 維護 | 買 |
| 10/14/2022 | 32.28% | 虎妞金融 | $128→$116 | 維護 | 買 |
| 2022年05月24日 | 2.63% | 羅森布拉特 | →$90 | 開始承保 | →購買 |
| 08/02/2021 | 31.14% | 巴靈頓研究公司 | →$115 | 升級 | 市場表現優於→ |
| 2021/01/29 | 1.49% | B.萊利證券 | $79→$89 | 維護 | 中性 |
| 06/24/2020 | -17.89% | B.萊利證券 | $68→$72 | 評級下調 | 購買→中性 |
| 05/05/2020 | -25.88% | 摩根大通 | $66→$65 | 維護 | 超重 |
| 05/05/2020 | -22.45% | B.萊利證券 | $71→$68 | 維護 | 買 |
| 04/15/2020 | -19.03% | B.萊利證券 | $60→$71 | 維護 | 買 |
| 03/24/2020 | -31.58% | B.萊利證券 | $57→$60 | 升級 | 中性→購買 |
| 03/24/2020 | -31.58% | B.萊利證券 | →$60 | 升級 | 中性→購買 |
| 03/18/2020 | -35% | B.萊利證券 | $71→$57 | 維護 | 中性 |
| 03/13/2020 | -24.73% | 摩根大通 | →$66 | 升級 | 中性→超重 |
| 2020/10/01 | -16.75% | B.萊利證券 | →$73 | 評級下調 | 購買→中性 |
| 2019年08月02日 | -16.75% | B.萊利證券 | $67→$73 | 維護 | 中性 |
| 2018年10月25日 | -28.16% | B.萊利證券 | $69→$63 | 維護 | 中性 |
| 2018年10月22日 | -8.77% | RF Lafferty | $81→$80 | 維護 | 買 |
What is the target price for Dolby Laboratories (DLB)?
杜比實驗室(Dolby實驗室)的目標價格是多少？
The latest price target for Dolby Laboratories (NYSE: DLB) was reported by Rosenblatt on July 28, 2023. The analyst firm set a price target for $93.00 expecting DLB to rise to within 12 months (a possible 6.06% upside). 8 analyst firms have reported ratings in the last year.
羅森布拉特於2023年7月28日報道了杜比實驗室(紐約證券交易所代碼：DLB)的最新目標價。這家分析公司將目標價定為93.00美元，預計DLB將在12個月內升至(可能上漲6.06%)。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Dolby Laboratories (DLB)?
杜比實驗室(DLB)最近的分析師評級是多少？
The latest analyst rating for Dolby Laboratories (NYSE: DLB) was provided by Rosenblatt, and Dolby Laboratories reiterated their buy rating.
杜比實驗室(紐約證券交易所代碼：DLB)的最新分析師評級是由Rosenblatt提供的，杜比實驗室重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Dolby Laboratories (DLB)?
杜比實驗室(DLB)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dolby Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dolby Laboratories was filed on July 28, 2023 so you should expect the next rating to be made available sometime around July 28, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與杜比實驗室的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。杜比實驗室的上一次評級是在2023年7月28日提交的，所以你應該預計下一次評級將在2024年7月28日左右的某個時候公佈。
Is the Analyst Rating Dolby Laboratories (DLB) correct?
分析師對杜比實驗室(Dolby實驗室)的評級正確嗎？
While ratings are subjective and will change, the latest Dolby Laboratories (DLB) rating was a reiterated with a price target of $0.00 to $93.00. The current price Dolby Laboratories (DLB) is trading at is $87.69, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的杜比實驗室(DLB)評級被重申，目標價在0.00美元至93.00美元之間。杜比實驗室目前的交易價格為87.69美元，在分析師的預測範圍內。